IL-33 antagonist-containing therapeutic agent for endometriosis
T Yoshimoto, JM Palumbo, VI Stone, T Kato… - US Patent …, 2022 - Google Patents
Based on the identification of IL-33 as an exacerbating factor in endometriosis and
adenomyosis uteri, a therapeutic agent for endometriosis and adenomyosis uteri has an IL …
adenomyosis uteri, a therapeutic agent for endometriosis and adenomyosis uteri has an IL …
Il-33 antagonist-containing therapeutic agent for endometriosis
知広， 善本， エム， ジョセフ， パルンボ， アイ… - 2019 - Google Patents
To provide a therapeutic agent for endometriosis and adenomyosis. IL-33 was identified as
an exacerbating factor in endometriosis and adenomyosis, and an IL-33 antagonist, which is …
an exacerbating factor in endometriosis and adenomyosis, and an IL-33 antagonist, which is …